Editorial Board


Alfio Ferlito, Udine University, Italy
Jifan Hu, Jilin University and Sun Yat-Sen University, China
Wolfgang Wrasidlo, Neuropore Therapies, USA
Yun Ji, Dr. Gattinoni's laboratory, USA
Cai Zhen, Wake Forest Baptist Medical Center, USA
Shyamala Maheswaran, Harvard university, USA
Wenxue Ma, University of California, USA
Alfred Au, UCSF Helen-Diller Comprehensive Cancer Center, USA
Manijeh Daneshmand, University of Ottawa, USA
Guangwei Du, University of Texas Health Science Center at Houston, USA
Li Xu, Xijing Hospital, China
Jose Russo, Fox Chase Cancer Center-Temple health, USA
Zhaohui Xiong, North Carolina Central University, USA
Baorui Liu, Medical School of Nanjing University, China
Chandini Marion Thirukkumaran, University of Calgary, Canada
Federico De Marco, National Cancer Institute - Rome, Italy
Massimiliano Berretta, National Cancer Institute, IRCCS, Italy
Keishiro Aoyagi, Kurume University School of Medicine, Japan
Magisetty Obulesu, University of Tsukuba, Japan
Takaaki Kobayashi, Kyorin university Hospital, Japan
Hildegard M. Schuller, University of Tennessee, USA
Shigeo Takebayashi, Yokohama City University Medical Center, Japan
Taiji Akamatsu, Nagano Prefectural Suzaka Hospital, Japan
Julius Strauss, National Cancer Institute, USA
Shahana Majid, UCSF and VA Medical Center, USA
Eli Avisar, University of Miami, USA
Atsushi Nagai, Institute for Molecular Science, National Institute of Natural Science, Japan
Motohide Shimazu, Tokyo Medical University & Keio University School of Medicine, Japan
Kazuyoshi Yagi, Niigata Prefectural Yoshida Hospital, Japan
Daniel J. Kaplan, University of Pittsburgh Medical Center, USA
Yasuo Maeda, Tohoku University, Japan
Tamotsu Tsukahara, Nagasaki University, Japan
Louiza Belkacemi, University of Houston, USA
Robert E. Heidel, University of Tennessee Graduate School of Medicine, USA
Volkmar Weissig, Midwestern University, USA
Amit K. Tiwari, The University of Toledo, USA
Hideki Fujita, Nihon University School of Medicine, Japan
Judy R. James, Mayo Clinic College of Medicine, USA
Fumio Bessho, Nihon Institute of Medical Science, Japan
Takemi Tanaka, University of Oklahoma Health Science Center, USA
You-Cheng Hseu, China Medical Univers, China
Ryuya Yamanaka, Kyoto Prefectural University of Medicine, Japan
Yang Shun-Fa, Chung Shan Medical University, Taiwan
Hideyuki Chiba, Omori Red Cross Hospital, Japan
Finn E. von Eyben, Lunds University and Southern Danish University, Sweden and Denmark
Hide Kohzaki, Shumei University, Japan
Alessandro Noseda, sigma-tau Research Switzerland SA, Switzerland
José Pablo Leone, University of Iowa, USA
Deric M. Park, National Cancer Institute(NIH), USA
Mehdi Shakibaei, Ludwig-Maximilians-University Munich, Germany
Hiroshi Tanooka, National Cancer Center Research, Japan
Daris Ferrari, San Paolo Hospital and University of Milan, Italy
Xiaodong Feng, California Northstate University College of Medicine, USA
Michael E. Salacz, University of Kansas Cancer Center, USA
Dexing Zeng, Medicine University of Pittsburgh School of Medicine, USA
Motohiko Suzuki, Nagoya City University, Japan
Mandip Singh Sachdeva, Florida A&M University, USA
Amira M. Gamal-Eldeen, National Research Centre, Cairo, Egypt
Swapan K. Ray, University of South Carolina School of Medicine, USA
Y. Alan Wang, The University of Texas MD Anderson Cancer Center, USA
Jun Liu, West Verginia University Cancer center, USA
Lalit Sehgal, The University of Texas MD Anderson Cancer Center, USA
Jerome Gnanaraj, Johns Hopkins University School of Medicine, USA

SHARE THIS ARTICLE


Renowned Editors

MIT, John Hopkins University, Stanford University, University of Michigan...300+

Rapid Peer Review

We assure 20 days rapid peer review process

Open Access

Open Access is the free, immediate, online availability of novel research

High Visibility

Published articles are easy to find on google, google scholar and other databases